328 related articles for article (PubMed ID: 27779655)
1. Human telomerase reverse transcriptase regulation by DNA methylation, transcription factor binding and alternative splicing (Review).
Avin BA; Umbricht CB; Zeiger MA
Int J Oncol; 2016 Dec; 49(6):2199-2205. PubMed ID: 27779655
[TBL] [Abstract][Full Text] [Related]
2. Physiological and pathological significance of human telomerase reverse transcriptase splice variants.
Bollmann FM
Biochimie; 2013 Nov; 95(11):1965-70. PubMed ID: 23933091
[TBL] [Abstract][Full Text] [Related]
3. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines.
Guilleret I; Benhattar J
Biochem Biophys Res Commun; 2004 Dec; 325(3):1037-43. PubMed ID: 15541393
[TBL] [Abstract][Full Text] [Related]
4. Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells.
Fujiwara M; Kamma H; Wu W; Hamasaki M; Kaneko S; Horiguchi H; Matsui-Horiguchi M; Satoh H
Int J Oncol; 2004 Apr; 24(4):925-30. PubMed ID: 15010831
[TBL] [Abstract][Full Text] [Related]
5. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
6. Subtelomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopharyngeal carcinoma cell lines.
Zhang ZX; Wang Y; Tao ZZ; Chen SM; Xiao BK; Zhou T
Cancer Biother Radiopharm; 2014 Sep; 29(7):289-94. PubMed ID: 25153197
[TBL] [Abstract][Full Text] [Related]
7. Inactive C-terminal telomerase reverse transcriptase insertion splicing variants are dominant-negative inhibitors of telomerase.
Zhu S; Rousseau P; Lauzon C; Gandin V; Topisirovic I; Autexier C
Biochimie; 2014 Jun; 101():93-103. PubMed ID: 24412622
[TBL] [Abstract][Full Text] [Related]
8. CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia.
Bechter OE; Eisterer W; Dlaska M; Kühr T; Thaler J
Exp Hematol; 2002 Jan; 30(1):26-33. PubMed ID: 11823034
[TBL] [Abstract][Full Text] [Related]
9. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
[TBL] [Abstract][Full Text] [Related]
10. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres.
Guilleret I; Benhattar J
Exp Cell Res; 2003 Oct; 289(2):326-34. PubMed ID: 14499633
[TBL] [Abstract][Full Text] [Related]
11. Expression of human telomerase reverse transcriptase splice variants is well correlated with low telomerase activity in osteosarcoma cell lines.
Fujiwara-Akita H; Maesawa C; Honda T; Kobayashi S; Masuda T
Int J Oncol; 2005 Apr; 26(4):1009-16. PubMed ID: 15753996
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase.
Zhang D; Sun X; Liu J; Xie X; Cui W; Zhu Y
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):71-8. PubMed ID: 25359865
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development.
Ulaner GA; Hu JF; Vu TH; Giudice LC; Hoffman AR
Int J Cancer; 2001 Mar; 91(5):644-9. PubMed ID: 11267974
[TBL] [Abstract][Full Text] [Related]
14. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues.
Saebøe-Larssen S; Fossberg E; Gaudernack G
BMC Mol Biol; 2006 Aug; 7():26. PubMed ID: 16939641
[TBL] [Abstract][Full Text] [Related]
15. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.
Guilleret I; Yan P; Grange F; Braunschweig R; Bosman FT; Benhattar J
Int J Cancer; 2002 Oct; 101(4):335-41. PubMed ID: 12209957
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of telomerase catalytic subunit hTERT generated by apoptotic endonuclease EndoG induces human CD4
Zhdanov DD; Vasina DA; Grachev VA; Orlova EV; Orlova VS; Pokrovskaya MV; Alexandrova SS; Sokolov NN
Eur J Cell Biol; 2017 Oct; 96(7):653-664. PubMed ID: 28886883
[TBL] [Abstract][Full Text] [Related]
18. Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
Quante M; Heeg S; von Werder A; Goessel G; Fulda C; Doebele M; Nakagawa H; Beijersbergen R; Blum HE; Opitz OG
Carcinogenesis; 2005 Nov; 26(11):1879-89. PubMed ID: 15958520
[TBL] [Abstract][Full Text] [Related]
19. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT).
Wick M; Zubov D; Hagen G
Gene; 1999 May; 232(1):97-106. PubMed ID: 10333526
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.
Ulaner GA; Hu JF; Vu TH; Giudice LC; Hoffman AR
Cancer Res; 1998 Sep; 58(18):4168-72. PubMed ID: 9751630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
